The following list sorts companies with the highest expenditures for research and development (R&D) for different years, mostly taken from the magazine Strategy+Business .
The 20 companies with the highest research and development expenses in 2022. [1]
Rank | Company | Country | Sector | Expenditures on R&D (billions of US$) |
---|---|---|---|---|
1 | Amazon | United States | Software and Internet | 73.21 |
2 | Alphabet Inc. | United States | Software and Internet | 39.50 |
3 | Meta Platforms, Inc. | United States | Software and Internet | 35.34 |
4 | Apple | United States | Computing and Electronics | 27.65 |
5 | Microsoft | United States | Software and Internet | 26.63 |
6 | Huawei | China | Computing and Electronics | 24.00 |
7 | Volkswagen Group | Germany | Automotive | 19.88 |
8 | Samsung Electronics | South Korea | Computing and Electronics | 19.29 |
9 | Intel | United States | Computing and Electronics | 17.53 |
10 | Roche Holding | Switzerland | Health Care | 14.72 |
11 | Johnson & Johnson | United States | Health Care | 14.6 |
12 | Merck & Co. | United States | Health Care | 13.55 |
13 | Pfizer | United States | Health Care | 11.43 |
14 | Novartis | Switzerland | Health Care | 10 |
15 | General Motors | United States | Automotive | 9.8 |
16 | AstraZeneca | United Kingdom/ Sweden | Health Care | 9.76 |
17 | Bristol Myers Squibb | United States | Health Care | 9.51 |
18 | Tencent | China | Software and Internet | 9.12 |
19 | Qualcomm | United States | Computing and Electronics | 8.52 |
20 | Alibaba Group | China | Software and Internet | 7.98 |
The 10 companies with the highest research and development expenses in 2020. [2]
Rank | Company | Country | Sector | Expenditures on R&D (billions of US$) |
---|---|---|---|---|
1 | Amazon | United States | Software and Internet | 42.74 |
2 | Alphabet Inc. | United States | Software and Internet | 27.57 |
3 | Huawei | China | Computing and Electronics | 22.04 |
4 | Microsoft | United States | Software and Internet | 19.27 |
5 | Apple | United States | Computing and Electronics | 18.75 |
5 | Samsung Electronics | South Korea | Computing and Electronics | 18.75 |
6 | Facebook, Inc. | United States | Software and Internet | 18.45 |
7 | Volkswagen Group | Germany | Automotive | |
8 | Intel | United States | Computing and Electronics | |
9 | Roche Holding | Switzerland | Health Care | |
10 | Johnson & Johnson | United States | Health Care |
The 50 companies with the highest research and development expenses in 2018. [3]
Rank | Company | Country | Sector | Expenditures on R&D (billions of US$) |
---|---|---|---|---|
1 | Amazon | United States | Software and Internet | 22.62 |
2 | Alphabet Inc. | United States | Software and Internet | 16.23 |
3 | Volkswagen Group | Germany | Automotive | 15.77 |
4 | Samsung Electronics | South Korea | Computing and Electronics | 15.31 |
5 | Microsoft | United States | Software and Internet | 14.74 |
6 | Huawei | China | Computing and Electronics | 13.60 |
7 | Intel | United States | Computing and Electronics | 13.10 |
8 | Apple Inc. | United States | Computing and Electronics | 11.58 |
9 | Roche Holding | Switzerland | Health Care | 10.80 |
10 | Johnson & Johnson | United States | Health Care | 10.55 |
11 | Daimler AG | Germany | Automotive | 10.40 |
12 | Merck & Co. | United States | Health Care | 10.21 |
13 | Toyota | Japan | Automotive | 10.02 |
14 | Novartis | Switzerland | Health Care | 8.51 |
15 | Ford Motor Company | United States | Automotive | 8.00 |
16 | Facebook, Inc. | United States | Software and Internet | 7.75 |
17 | Pfizer | United States | Health Care | 7.66 |
18 | BMW | Germany | Automotive | 7.33 |
19 | General Motors | United States | Automotive | 7.30 |
20 | Robert Bosch GmbH | Germany | Industrials | 7.12 |
21 | Honda | Japan | Automotive | 7.08 |
22 | Sanofi | France | Health Care | 6.57 |
23 | Bayer | Germany | Health Care | 6.19 |
24 | Siemens | Germany | Industrials | 6.10 |
25 | Oracle Corporation | United States | Software and Internet | 6.09 |
26 | Cisco Systems | United States | Computing and Electronics | 6.06 |
27 | GlaxoSmithKline | United Kingdom | Health Care | 6.05 |
28 | Bristol-Myers Squibb | United States | Health Care | 5.96 |
29 | Celgene | United States | Health Care | 5.92 |
30 | Nokia | Finland | Computing and Electronics | 5.90 |
31 | IBM | United States | Computing and Electronics | 5.79 |
32 | Qualcomm | United States | Computing and Electronics | 5.47 |
33 | AstraZeneca | United Kingdom/ Sweden | Health Care | 5.41 |
34 | Eli Lilly and Company | United States | Health Care | 5.28 |
35 | Fiat Chrysler Automobiles | Italy/ United States | Automotive | 5.14 |
36 | AbbVie Inc. | United States | Health Care | 4.98 |
37 | General Electric | United States | Industrials | 4.80 |
38 | Dell | United States | Computing and Electronics | 4.76 |
39 | Ericsson | Sweden | Computing and Electronics | 4.63 |
40 | Nissan | Japan | Automotive | 4.62 |
41 | Sony | Japan | Computing and Electronics | 4.32 |
42 | Panasonic | Japan | Computing and Electronics | 4.23 |
43 | Denso | Japan | Automotive | 4.21 |
44 | SAP SE | Germany | Software and Internet | 4.03 |
45 | Gilead Sciences | United States | Health Care | 3.73 |
46 | Continental AG | Germany | Automotive | 3.73 |
47 | Boehringer Ingelheim | Germany | Health Care | 3.69 |
48 | Alibaba Group | China | Software and Internet | 3.63 |
49 | Amgen | United States | Health Care | 3.56 |
50 | Renault | France | Automotive | 3.55 |
The 20 companies with the highest research and development expenses in 2017 according to the Global Innovation 1000. [4]
Rank | Company | Country | Sector | Expenditures on R&D (billions of US$) |
---|---|---|---|---|
1 | Amazon | United States | Software and Internet | 16.1 |
2 | Alphabet Inc. | United States | Software and Internet | 13.9 |
3 | Intel | United States | Computing and Electronics | 12.7 |
4 | Samsung | South Korea | Computing and Electronics | 12.7 |
5 | Volkswagen Group | Germany | Automotive | 12.1 |
6 | Microsoft | United States | Software and Internet | 12.0 |
7 | Roche Holding | Switzerland | Health Care | 11.4 |
8 | Merck & Co. | United States | Health Care | 10.1 |
9 | Apple Inc. | United States | Computing and Electronics | 10.0 |
10 | Novartis | Switzerland | Health Care | 9.6 |
11 | Toyota | Japan | Automotive | 9.3 |
12 | Johnson & Johnson | United States | Health Care | 9.1 |
13 | General Motors | United States | Automotive | 8.1 |
14 | Pfizer | United States | Health Care | 7.9 |
15 | Ford Motor Company | United States | Automotive | 7.3 |
16 | Daimler AG | Germany | Automotive | 6.9 |
17 | Oracle Corporation | United States | Software and Internet | 6.8 |
18 | Cisco Systems | United States | Computing and Electronics | 6.3 |
19 | Honda | Japan | Automotive | 6.2 |
20 | Facebook, Inc. | United States | Software and Internet | 5.9 |
The 20 companies with the highest research and development expenses in 2014 according to the Global Innovation 1000. [5]
Rank | Company | Country | Sector | Expenditures on R&D (billions of US$) |
---|---|---|---|---|
1 | Volkswagen Group | Germany | Automotive | 13.5 |
2 | Samsung | South Korea | Computing and Electronics | 13.4 |
3 | Intel | United States | Computing and Electronics | 10.6 |
4 | Microsoft | United States | Software and Internet | 10.4 |
5 | Roche Holding | Switzerland | Health Care | 10.0 |
6 | Novartis | Switzerland | Health Care | 9.9 |
7 | Toyota | Japan | Automotive | 9.1 |
8 | Johnson & Johnson | United States | Health Care | 8.2 |
9 | United States | Software and Internet | 8.0 | |
10 | Merck & Co. | United States | Health Care | 7.5 |
11 | General Motors | United States | Automotive | 7.2 |
12 | Daimler AG | Germany | Automotive | 7.0 |
13 | Pfizer | United States | Health Care | 6.7 |
14 | Amazon | United States | Software and Internet | 6.4 |
15 | Ford Motor Company | United States | Automotive | 6.4 |
16 | Sanofi Aventis | France | Health Care | 6.3 |
17 | Honda | Japan | Automotive | 6.3 |
18 | IBM | United States | Computing and Electronics | 6.2 |
19 | GlaxoSmithKline | United Kingdom | Health Care | 6.1 |
20 | Cisco Systems | United States | Computing and Electronics | 5.9 |
The 20 companies with the highest research and development expenses in 2011 according to the Global Innovation 1000. [6]
Rank | Company | Country | Sector | Expenditures on R&D (millions of US$) |
---|---|---|---|---|
1 | Roche Holding | Switzerland | Health Care | 9,646 |
2 | Pfizer | United States | Health Care | 9,413 |
3 | Novartis | Switzerland | Health Care | 9,070 |
4 | Microsoft | United States | Software and Internet | 8,714 |
5 | Merck & Co. | United States | Health Care | 8,591 |
6 | Toyota | Japan | Automotive | 8,546 |
7 | Samsung | South Korea | Computing and Electronics | 7,873 |
8 | Nokia | Finland | Computing and Electronics | 7,778 |
9 | General Motors | United States | Automotive | 6,962 |
10 | Johnson & Johnson | United States | Health Care | 6,844 |
11 | Intel | United States | Computing and Electronics | 6,576 |
12 | Panasonic | Japan | Computing and Electronics | 6,176 |
13 | GlaxoSmithKline | United Kingdom | Health Care | 6,127 |
14 | Volkswagen Group | Germany | Automotive | 6,086 |
15 | IBM | United States | Computing and Electronics | 6,026 |
16 | Sanofi Aventis | France | Health Care | 5,836 |
17 | Honda | Japan | Automotive | 5,704 |
18 | AstraZeneca | United Kingdom | Health Care | 5,318 |
19 | Cisco Systems | United States | Computing and Electronics | 5,273 |
20 | Siemens | Germany | Industrials | 5,217 |
The 20 companies with the highest research and development expenses in 2008 according to the Global Innovation 1000. [7]
Rank | Company | Country | Sector | Expenditures on R&D (millions of US$) |
---|---|---|---|---|
1 | Toyota | Japan | Automotive | 8,386 |
2 | General Motors | United States | Automotive | 8,100 |
3 | Pfizer | United States | Health Care | 8,089 |
4 | Nokia | Finland | Computing and Electronics | 7,727 |
5 | Johnson & Johnson | United States | Health Care | 7,680 |
6 | Ford Motor Company | United States | Automotive | 7,500 |
7 | Microsoft | United States | Software and Internet | 7,121 |
8 | Roche Holding | Switzerland | Health Care | 6,985 |
9 | Samsung | South Korea | Computing and Electronics | 6,536 |
10 | GlaxoSmithKline | United Kingdom | Health Care | 6,476 |
11 | Novartis | Switzerland | Health Care | 6,430 |
12 | Sanofi Aventis | France | Health Care | 6,208 |
13 | IBM | United States | Computing and Electronics | 6,153 |
14 | Intel | United States | Computing and Electronics | 5,755 |
15 | AstraZeneca | United Kingdom | Health Care | 5,162 |
16 | Honda | Japan | Automotive | 5,142 |
17 | Merck & Co. | United States | Health Care | 4,883 |
18 | Panasonic | Japan | Computing and Electronics | 4,850 |
19 | Volkswagen Group | Germany | Automotive | 4,757 |
20 | Sony | Japan | Computing and Electronics | 4,553 |
Innovation is the practical implementation of ideas that result in the introduction of new goods or services or improvement in offering goods or services. ISO TC 279 in the standard ISO 56000:2020 defines innovation as "a new or changed entity, realizing or redistributing value". Others have different definitions; a common element in the definitions is a focus on newness, improvement, and spread of ideas or technologies.
The knowledge economy, or knowledge-based economy, is an economic system in which the production of goods and services is based principally on knowledge-intensive activities that contribute to advancement in technical and scientific innovation. The key element of value is the greater dependence on human capital and intellectual property as the source of innovative ideas, information, and practices. Organisations are required to capitalise on this "knowledge" in their production to stimulate and deepen the business development process. There is less reliance on physical input and natural resources. A knowledge-based economy relies on the crucial role of intangible assets within the organisations' settings in facilitating modern economic growth.
Research and development is the set of innovative activities undertaken by corporations or governments in developing new services or products. R&D constitutes the first stage of development of a potential new service or the production process.
Corvinus University of Budapest is a private research university in Budapest, Hungary. The university currently has an enrolment of approximately 9,600 students, with a primary focus on business administration, economics, and social sciences, operating in Budapest and Székesfehérvár since 1948. Corvinus University accepts students at six faculties and offer courses leading to degrees at the bachelor, master and doctoral level in specialisations taught in Hungarian, English, French or German.
Research funding is a term generally covering any funding for scientific research, in the areas of natural science, technology, and social science. Different methods can be used to disburse funding, but the term often connotes funding obtained through a competitive process, in which potential research projects are evaluated and only the most promising receive funding. It is often measured via Gross domestic expenditure on R&D (GERD).
Joseph "Yossi" Vardi is an Israeli entrepreneur and investor. He is an Israeli entrepreneur and investor, known for his involvement in the early development of Israel's high-tech sector and the Israeli internet industry. He has been involved in the founding and development of over 85 high-tech companies across various fields, including software, energy, internet, mobile, electro-optics, and water technology, over a span of more than 47 years.
IESE Business School is a Catholic graduate business school at the University of Navarra. It was established in Barcelona in 1958 by Opus Dei. From 1963, in collaboration with Harvard Business School, it offers a two-year Master of Business Administration degree, an executive MBA, and executive education courses. It has other campuses in Madrid, Munich, New York City and São Paulo.
Richard Lui is an American author, journalist, and filmmaker. He anchors for MSNBC and NBC News. Lui is currently a breaking news anchor for NBC and MSNBC, broadcasting from 30 Rockefeller Plaza in Midtown Manhattan, New York City. prior to that role he was a co-host of Early Today, and anchor of MSNBC daytime coverage. He was formerly at CNN Worldwide. At CNN Worldwide he became the first Asian American male to anchor a daily, national cable news show when he solo anchored the 10 a.m. hour on CNN Headline News. Mediaite ranked Lui among the top 100 in news buzz on its "Power Grid Influence Index of TV Anchors and Hosts" and one of "The 50 Sexiest in TV News".
Awa Marie Coll-Seck is a Senegalese infectious diseases specialist and politician who served as Minister of Health of Senegal from 2001 to 2003 and again from 2012 to 2017. She also served as former Executive Director of the Roll Back Malaria Partnership and is on the board of directors of several notable global health organizations. She is an agenda contributor of the World Economic Forum.
This is a list of key international rankings of Costa Rica
The Stop TB Partnership was established in 2001 to eliminate tuberculosis as a public health problem. Its 2000 partner organizations include international, nongovernmental and governmental organizations and patient groups. The secretariat is based in Geneva, Switzerland, and, since 2015, has been administered by UNOPS. Previously it was hosted by the World Health Organization.
Hubert Joly is a businessman and Harvard Business School faculty member who formerly served as chairman and CEO of Best Buy. He is also the former president, CEO and director of Carlson, a global hospitality and travel conglomerate based in Minneapolis, Minnesota, US.
Maya Dangelas is the Executive Chairman of Tan Tao Group, President of Tan Tao University, Chair of the Vietnam-US Business Forum, Member of ESCAP Business Advisory Council, Member of ASEAN Business Advisory Council, and Member of World Economic Forum’s Global Agenda Council on South-East Asia.
The State Secretariat for Education, Research and Innovation (SERI) within the Federal Department of Economic Affairs, Education and Research is the federal government's specialised agency for national and international matters concerning education, research and innovation policy.
Innovation districts are urban geographies of innovation where R&D strong institutions, companies, and other private actors develop integrated strategies and solutions to develop thriving innovation ecosystems–areas that attract entrepreneurs, startups, and business incubators. Unlike science parks, innovation districts are physically compact, leverage density and high levels of accessibility, and provide a “mash up” of activities including housing, office, and neighborhood-serving amenities. Districts signify the collapse back of innovation into cities and is increasingly used as a way to revitalize the economies of cities and their broader regions. As of 2019, there are more than 100 districts worldwide.
Geotab Inc. is a Canadian technology company headquartered in Oakville, Ontario. The company develops and markets telematics hardware and software for use with motor vehicles. The company's products are primarily used for fleet management, including on-board diagnostics, electronic logging, route optimization, accident data recording and CO2 emissions reporting.
The Tang Prize is a set of biennial international awards bestowed in four fields: Sustainable Development, Biopharmaceutical Science, Sinology, and Rule of Law. Nomination and selection are conducted by an independent selection committee, which is formed in partial cooperation with the Academia Sinica, Taiwan's top research institution.
Alfredo De Massis is a professor of Entrepreneurship and Family Business at the International Institute for Management Development (IMD) and at the Free University of Bozen-Bolzano. He chairs the Scientific Committee of FAmily Business Risorse per l'Italia and is a member of the Scientific Board of the Italian Family Officer Association (AIFO). According to Family Capital, De Massis is among the top 25 star professors of family business in the world. In 2022, he was nominated in the Family Capital's 100 Family Business Influencers list.
Deep technology or hard tech is a classification of organization, or more typically startup company, with the expressed objective of providing technology solutions based on substantial scientific or engineering challenges. They present challenges requiring lengthy research and development, and large capital investment before successful commercialization. Their primary risk is technical risk, while market risk is often significantly lower due to the clear potential value of the solution to society. The underlying scientific or engineering problems being solved by deep tech and hard tech companies generate valuable intellectual property and are hard to reproduce.
{{cite web}}
: CS1 maint: multiple names: authors list (link){{cite web}}
: CS1 maint: multiple names: authors list (link){{cite web}}
: CS1 maint: multiple names: authors list (link)